---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-017875"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2024-02-21T23:59:59+00:00"
generated_at: "2026-06-05T21:44:45.135489+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# MEI Pharma signs $25M ATM equity facility, initially capped at $10.3M due to float limit

## Summary
- Entered into Capital on Demand Sales Agreement with JonesTrading to sell up to $25M of common stock in ATM offerings.
- Initial offering limit is $10.3M because public float is under $75M; may increase if float grows.
- Also filed a universal Form S-3 registration statement for up to $100M in securities.
- Agent commission is 3.0% of gross proceeds from shares sold under the agreement.
- No assurance any shares will be issued; agreement can be terminated by either party.

## SEC filing metadata
- accession: 0000950170-24-017875
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2024-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000095017024017875/0000950170-24-017875-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000095017024017875/meip-20240221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-017875
- JSON: https://secwatch.observer/filing/0000950170-24-017875.json
- Plain text: https://secwatch.observer/filing/0000950170-24-017875.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.